We met with Lauren Troy, from Royal Prince Alfred Hospital, Sydney, Australia at ERS 2019 in Madrid to discuss result of the COLDICE study into transbronchial lung cryobiopsy for interstitial lung disease diagnosis.
1. In what clinical situation is a lung biopsy required to confirm a diagnosis of interstitial lung disease? (0:05)
2. What are the limitations of surgical lung biopsy in the diagnosis of interstitial lung disease? (0:41)
3. What is transbronchial lung cryobiopsy and what are its advantages? (1:30)
4. What is known about the safety of this procedure? (2:31)
5. Could you tell us a little about the aims and design of the COLDICE study? (3:21)
Speaker disclosures: Lauren Troy has nothing to disclose in relation to this video interview.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Respiratory Society (ERS) International Congress 2019, Madrid, Spain.
Share this Video
Related Videos In Interstitial Lung Disease
Clinical trials and current standard of care in idiopathic pulmonary fibrosis: Steven D. Nathan, ATS 2023
Idiopathic pulmonary fibrosis (IPF) is a serious chronic lung disease which results in symptoms such as shortness of breath and dry cough and is caused by fibrosis of the lungs. It was a pleasure to talk with Dr. Steven D. Nathan (Inova Fairfax Hospital, Falls Church, VA, USA) to discuss the incidence, prognosis and pathology of […]
TETON-1 & -2 phase 3 studies of treprostinil in IPF – baseline characteristics: Steven D. Nathan, ATS 2023
The TETON program consists of two currently recruiting phase 3 randomized, double-blind, placebo-controlled studies that are investigating the efficacy and safety of inhaled treprostinil in idiopathic pulmonary fibrosis (NCT04708782, NCT05255991). It was a pleasure to talk with Dr. Steven D. Nathan (Inova Fairfax Hospital, Falls Church, VA, USA) around the aims and design of the TETON program […]
Jean Elwing, CHEST 2022: Inhaled treprostinil for pulmonary hypertension due to interstitial lung disease – the INCREASE OLE study
INCREASE OLE was the open-label extension of the INCREASE study (NCT02630316), which investigated the safety and efficacy of inhaled treprostinil in patients with pulmonary hypertension due to interstitial lung disease. We caught up with Prof. Jean Elwing (UC Health, Cincinnati, OH, USA) to discuss the methodology, inclusion criteria, and safety and tolerability findings from the […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!